Abstract:All authors have no conflict of interest to declare. Abstract
2The clinical and pathologic features of 70 juvenile granulosa cell tumors of the testis are presented. The patients were from 30-weeks gestational age to 10 years old; 60 of 67 (90%) whose age is known to us were < 6 months old. Sixty-two underwent gonadectomy, 6 wedge excision, and 2 only biopsy. Twenty-six tumors were left-sided, and 22 right-sided. Six occurred in an undescended testis and 2 in dysgenetic gonads. The most common presentation was… Show more
“…A clinicopathologic study of 70 cases of JGCT performed by Kao et al described 79% of cases with mixed follicular and solid patterns staining positive for inhibin, calretinin, WT1 and FOXL2. AFP staining was uniformly negative except for one case that showed focal reactivity 2 . Our case would be the second one reporting the same AFP positivity in this type of tumor.…”
We report on a case of juvenile granulosa cell tumor of the testicle in a neonate, a rare testicular tumor in children. No genital ambiguity, anatomic abnormalities, nor sex chromosome aneuploidy was noted in this patient. In our case, despite positive staining for alpha-fetoprotein which is most consistent with yolk sac tumors, all clinical, gross anatomic, histologic, and other immunohistologic characteristics of the tumor remained consistent with the diagnosis of juvenile granulosa cell tumor. The alpha-fetoprotein positivity of the tumor remains unexplained.
“…A clinicopathologic study of 70 cases of JGCT performed by Kao et al described 79% of cases with mixed follicular and solid patterns staining positive for inhibin, calretinin, WT1 and FOXL2. AFP staining was uniformly negative except for one case that showed focal reactivity 2 . Our case would be the second one reporting the same AFP positivity in this type of tumor.…”
We report on a case of juvenile granulosa cell tumor of the testicle in a neonate, a rare testicular tumor in children. No genital ambiguity, anatomic abnormalities, nor sex chromosome aneuploidy was noted in this patient. In our case, despite positive staining for alpha-fetoprotein which is most consistent with yolk sac tumors, all clinical, gross anatomic, histologic, and other immunohistologic characteristics of the tumor remained consistent with the diagnosis of juvenile granulosa cell tumor. The alpha-fetoprotein positivity of the tumor remains unexplained.
“…According to the current World Health Organization (WHO) classification of Tumors of the Urinary System and Male Genital Organs, two histologic subtypes are distinguished: The juvenile tGrCT and the less frequent adult tGrCT (Idrees et al 2017 ). While the juvenile subtype accounts for 6% of all prepubertal testicular tumors and represents the most frequent congenital testicular tumor (Kao et al 2015 ), the adult tGrCT is rare and only reported in small case series and case reports. For both histological subtypes, the risk of metastatic spread is ill defined (Cecchetto et al 2010 ; Mostofi et al 1959 ).…”
Purpose
Testicular granulosa cell tumors (tGrCT) are rare sex cord-stromal tumors. This review aims to synthesize the available evidence regarding the clinical presentation and clinicopathological characteristics, treatment and outcomes.
Methods
We conducted a systematic literature search using the most important research databases. Whenever feasible, we extracted the data on individual patient level.
Results
From 7863 identified records, we included 88 publications describing 239 patients with tGrCT. The majority of the cases were diagnosed with juvenile tGrCT (166/239, 69%), while 73/239 (31%) patients were diagnosed with adult tGrCT. Mean age at diagnosis was 1.5 years (± 5 SD) for juvenile tGrCT, and 42 years (± 19 SD) for adult tGrCT. Information on primary treatment was available in 231/239 (97%), of which 202/231 (87%) were treated with a radical orchiectomy and 20/231 (9%) received testis sparing surgery (TSS). Local recurrence after TSS was observed in 1/20 (5%) cases. Metastatic disease was never observed in men with juvenile tGrCT but in 7/73 (10%) men with adult tGrCT. In 5/7 men with metastatic tGrCT, metastases were diagnosed at initial staging, while 2/7 patients developed metastases after 72 and 121 months of follow-up, respectively. Primary site of metastasis is represented by the retroperitoneal lymph nodes, but other sites including lungs, liver, bone and inguinal lymph nodes can also be affected. In comparison with non-metastatic adult tGrCT, men with metastatic adult tGrCT had significantly larger primary tumors (70 vs 24 mm, p 0.001), and were more likely to present with angiolymphatic invasion (57% vs 4%, p 0.002) or gynecomastia (29% vs 3%, p 0.019). In five out of seven men with metastatic disease, resection of metastases or platinum-based chemotherapy led to complete remission.
Conclusion
Juvenile tGrCT represent a benign entity whereas adult tGCTs have metastatic potential. Tumor size, presence of angiolymphatic invasion or gynecomastia represent risk factors for metastatic disease. The published literature supports the use of testis sparing surgery but there is only limited experience with adjuvant therapies. In the metastatic setting, the reviewed literature suggests that aggressive surgical and systemic treatment might cure patients.
“…1 It is frequently diagnosed in the neonatal period; it is uncommon in older children and exceptional in adults. 2 Typical presentation is a painless neonatal scrotal mass 3 ; occasionally it occurs in cryptorchidic testes 3 4 5 or in infants with abnormal karyotypes and ambiguous genitalia 3 ; all cases reported have had a benign outcome. 3 6 Inguinal orchiectomy was invariably considered the treatment of choice but new treatment trends advocate a trans-scrotal approach 7 and testis-sparing surgery where preoperative staging determines that this is safe.…”
Section: Introductionmentioning
confidence: 99%
“…2 Typical presentation is a painless neonatal scrotal mass 3 ; occasionally it occurs in cryptorchidic testes 3 4 5 or in infants with abnormal karyotypes and ambiguous genitalia 3 ; all cases reported have had a benign outcome. 3 6 Inguinal orchiectomy was invariably considered the treatment of choice but new treatment trends advocate a trans-scrotal approach 7 and testis-sparing surgery where preoperative staging determines that this is safe. 6 8 We report a case of JGCT of the testis prenatally diagnosed, an event described only twice in the literature so far, 7 9 followed by inguinal orchiectomy.…”
Prepubertal primary testicular tumors account for ∼1% of all pediatric solid tumors. We report a new case of prenatal diagnosis of juvenile-type granulosa cell tumor (JGCT). A fetal ultrasound performed at the 38th week of gestation for suspected nonvertex presentation identified a left multilocular septated cystic testicular mass, suggestive for JGCT. At birth, a painless left scrotal mass was detected. Ultrasound re-evaluation excluded torsion of the testis. Tumor markers and abdominal ultrasound were normal for age. Inguinal exploration revealed a cystic mass beneath the tunica albuginea that had replaced all the normal parenchyma. Since organ-sparing surgery was thus not feasible, an orchiectomy was performed and diagnosis of JGCT was confirmed. At 7-year follow-up, the child presented an uneventful outcome. Our case shows that neonatal JGCT, which has an intrauterine genesis, can be diagnosed prenatally by ultrasound in the last weeks of pregnancy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.